LSV Asset Management »

Keros Therapeutics shares owned by LSV Asset Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by LSV Asset Management from 13F filings

Historical chart of LSV Asset Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by LSV Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by LSV Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $470k 23k 20.35

More positions owned by LSV Asset Management

Alphabet Inc Class A cs (GOOGL)
Citigroup (C)
Cisco Systems (CSCO)
Qualcomm (QCOM)
Wells Fargo & Company (WFC)
Bank of New York Mellon Corporation (BK)
General Motors Company (GM)
At&t (T)
State Street Corporation (STT)
Merck & Co (MRK)
Gilead Sciences (GILD)
Verizon Communications (VZ)
Fox Corp (FOXA)
eBay (EBAY)
Bristol Myers Squibb (BMY)

View all positions for LSV Asset Management

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
State Street Corporation
Alkeon Capital Management
Madison Avenue Partners
OrbiMed Advisors
Qube Research & Technologies
Jacobs Levy Equity Management
Federated Investors
Geode Capital Management
Nantahala Capital Management
Renaissance Technologies
Goldman Sachs Group

View all funds holding Keros Therapeutics